Jpmorgan Chase & CO Oncology Institute, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 171 shares of TOI stock, worth $49. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171
Previous 170
0.59%
Holding current value
$49
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TOI
# of Institutions
35Shares Held
17.5MCall Options Held
0Put Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY3.36MShares$974,4150.02% of portfolio
-
Tiff Advisory Services Inc2.63MShares$763,5360.29% of portfolio
-
Cincinnati Insurance CO2.03MShares$589,8730.01% of portfolio
-
Kent Lake Pr LLC Anasco, PR2MShares$580,0000.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$517,2010.0% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $21.3M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...